FDA Inspection 1207366 — Suzanne R. Broadhurst, DVM
The FDA completed an inspection of Suzanne R. Broadhurst, DVM on May 24, 2023 in Seattle, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 24, 2023
- Fiscal Year
- 2023
- Product Type
- Veterinary
- Project Area
- Bioresearch Monitoring
- Location
- Seattle, WA (United States)
Additional Details
Clinical Investigator (CI)